Pharmaceutical giant to axe 90 at its Cork plant
PHARMACEUTICAL giant Merck Sharpe & Dohme (MSD) is to axe 90 jobs at one of its main Irish plants.
The jobs will be lost at the firm's facility at Brinny in Cork. Workers were briefed on the bad news at a staff meeting.
The MSD redundancies follow the decision by the US giant to slash over 700 jobs from their Irish operations in 2009 after the merger of Merck Sharpe & Dohme and rival firm, Schering Plough.
MSD, which is based in New Jersey, currently employs over 2,300 people in Cork, Dublin, Carlow, Tipperary and Wicklow.
The Brinny plant -- the focus of €300m investment since 2004 -- was developed in 1980 by Schering Plough and employs 455 staff.
MSD's Brinny site manager, Matt Corcoran, said the redundancies were voluntary but unavoidable given global market conditions.
"Our immediate priority now is to work with and support all our employees during the consultation process," he added.
Company sources dismissed as "absolute nonsense" suggestions that the future of the entire Brinny site was in doubt.